Related Experiment Video

Updated: May 3, 2026

Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia
10:49

Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia

Published on: September 18, 2013

17.5K

Brief report on pediatric oncology in Bangladesh

Afiqul Islam1, Tim Eden1

  • 1Department of Pediatric Oncology, Bangabandhu Sheikh Majib Medical University, Dhaka, Bangladesh.

South Asian Journal of Cancer
|January 24, 2014
PubMed

Insights

Childhood cancer is a growing concern as other causes of death decline. Addressing awareness, late diagnosis, and treatment barriers is crucial for improving pediatric cancer care.

Area of Science:

  • Pediatric Oncology
  • Public Health Initiatives
  • Global Health Challenges

Background:

  • Childhood cancer is an increasing threat to life.
  • Decreasing mortality from infections and malnutrition highlights this shift.
  • Maternal and child health initiatives have improved survival rates for other conditions.

Purpose of the Study:

  • To outline the emerging challenges in pediatric cancer care.
  • To emphasize the need for comprehensive services for children with cancer.
  • To identify key barriers hindering effective childhood cancer management.

Main Methods:

  • This study is a review of current challenges in pediatric oncology.
  • It synthesizes information on awareness, diagnosis, and treatment barriers.
  • No specific patient data or clinical trials were conducted.

Main Results:

  • Significant challenges include low professional and public awareness.
  • Late diagnosis and the perception of incurability impede treatment.
  • Treatment refusal, abandonment, toxic deaths, and drug accessibility issues are major hurdles.

Conclusions:

  • Comprehensive services are essential for improving outcomes in childhood cancer.
  • Overcoming awareness, diagnostic, and treatment-related barriers is critical.
  • Addressing drug costs and availability is vital for equitable pediatric cancer care.

Keywords:
BangladeshCancerChildren

More Related Videos

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

20.6K
Establishment of Orthotopic Patient-derived Xenograft Models for Brain Tumors using a Stereotaxic Device07:44

Establishment of Orthotopic Patient-derived Xenograft Models for Brain Tumors using a Stereotaxic Device

Published on: May 2, 2025

1.1K

Related Concept Videos

The Retinoblastoma Gene01:20

The Retinoblastoma Gene

2.1K
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
967
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
410
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
408
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
554
Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
863